5-(2,6-Dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine hydrochloride hydrate → Buparlisib Hydrochloride
Reaction equation
[ClH:1].O.[N:3]1([C:9]2[N:14]=[C:13]([C:15]3[C:16]([C:22]([F:25])([F:24])[F:23])=[CH:17][C:18]([NH2:21])=[N:19][CH:20]=3)[CH:12]=[C:11]([N:26]3[CH2:31][CH2:30][O:29][CH2:28][CH2:27]3)[N:10]=2)[CH2:8][CH2:7][O:6][CH2:5][CH2:4]1>C(OC(C)C)(=O)C>[ClH:1].[N:3]1([C:9]2[N:14]=[C:13]([C:15]3[C:16]([C:22]([F:25])([F:23])[F:24])=[CH:17][C:18]([NH2:21])=[N:19][CH:20]=3)[CH:12]=[C:11]([N:26]3[CH2:27][CH2:28][O:29][CH2:30][CH2:31]3)[N:10]=2)[CH2:4][CH2:5][O:6][CH2:7][CH2:8]1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
40 mg of 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)pyridin-2-amine monohydrate monohydrochloride of Example 6 is equilibrated in 0.5 mL isopropyl acetate in a vial at 25° C.±0.1 for 24 hours equilibration time (with constant agitation). The resulting solids are collected by filtration, air-dried to remove residual excess solvent and then analyzed by X-ray powder diffraction to yield Polymorph Form SC of the monohydrochloride salt of the compound of Formula A.
Workup
- customvial at 25° C.
- customfor 24 hours
- filtrationThe resulting solids are collected by filtration
- customair-dried
- customto remove residual excess solvent
Sources & evidence
- ORD record
- ord-ecadb65daa5f43f7b9c0d94bd7928d22
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181215B2
Reaction notes
Loading…